Dow Jones

40,211.72

0.53%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Adamis Pharmaceuticals Corporation (ADMP)
Adamis Pharmaceuticals Corporation (ADMP) Noticias

ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ADMP

<< Anterior 1 2 3 4 5 6 7 8 9 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
01/07/2018	19:00	GlobeNewswire Inc.	Adamis Pharmaceuticals Announces Distribution and Commercialization Agreement for Symjepi	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
07/06/2018	15:48	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
11/05/2018	16:28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
10/05/2018	16:51	GlobeNewswire Inc.	Adamis Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
10/05/2018	15:44	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
30/04/2018	17:21	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
16/03/2018	05:12	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
15/03/2018	16:59	GlobeNewswire Inc.	Adamis Pharmaceuticals Discusses 2017 Highlights and Business Update	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
08/03/2018	08:00	GlobeNewswire Inc.	Adamis Pharmaceuticals Announces Publication of a New Human Factors Study Comparing Its Symjepi™ Epinephrine Prefilled Syri...	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
06/03/2018	08:00	GlobeNewswire Inc.	Adamis Pharmaceuticals Provides Update on Data Presented at the American Academy of Allergy, Asthma and Immunology (AAAAI) Jo...	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
23/02/2018	17:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
23/02/2018	08:00	GlobeNewswire Inc.	Adamis Pharmaceuticals Updates Symjepi Commercialization Plans	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
14/02/2018	13:55	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
12/02/2018	08:00	GlobeNewswire Inc.	Adamis Pharmaceuticals Announces FDA Acceptance for Review for the Supplemental New Drug Application of Its Low Dose Symjep...	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
06/12/2017	15:29	GlobeNewswire Inc.	US Compounding, a Subsidiary of Adamis Pharmaceuticals, Develops a Unique Compound to Manage Ulcers in Horses	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
04/12/2017	15:05	GlobeNewswire Inc.	Adamis Pharmaceuticals Announces Submission of Investigational New Drug (IND) Application to the FDA for New Product Candidat...	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
01/12/2017	08:00	GlobeNewswire Inc.	Adamis Pharmaceuticals Announces Presentation of Results of a Human Factors Study Conducted With Its Newly Approved Epinephri...	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
29/11/2017	15:05	GlobeNewswire Inc.	Adamis Pharmaceuticals Submits Prior Approval Supplement to FDA for the Pediatric Version of Symjepi	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
21/11/2017	06:30	GlobeNewswire Inc.	Recent Analysis Shows Universal Display, Adamis Pharmaceuticals, Calumet Specialty Products Partners, Eldorado Resorts, PHH, ...	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
25/09/2017	15:32	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
22/08/2017	05:03	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
23/06/2017	15:48	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
15/06/2017	13:31	GlobeNewswire Inc.	Adamis Pharmaceuticals Receives FDA Approval for Its Epinephrine Pre-Filled Syringe	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
26/04/2017	15:05	GlobeNewswire Inc.	Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
24/04/2017	16:10	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
24/04/2017	07:32	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
21/04/2017	14:07	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
21/04/2017	12:35	Edgar (US Regulatory)	Registration of Additional Securities (up to 20%) (s-3mef)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
21/04/2017	08:13	GlobeNewswire Inc.	Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation
21/04/2017	08:08	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:ADMP	Adamis Pharmaceuticals Corporation